Philip Astley-Sparke

Companies

• enGene Therapeutics Inc.Board member Jul 8, 2025 to now¹
• Replimune Group, Inc.Board member Apr 2, 2020 to now²
• Replimune Group, Inc.Chair Jul 19, 2018 to Aug 30, 2024³
• Replimune Group, Inc.Chief executive officer Apr 2, 2020 to May 18, 2023²
• Forbion European Acquisition Corp.Board member Dec 9, 2021 to Dec 9, 2021⁴
• uniQure N.V.Board member Jan 4, 2017 to Mar 4, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RReplimune Group, Inc. REPL1,362,414 shares⁶$15.0M at $10.99Aug 20, 2026
• ETenGene Therapeutics Inc. ENGN20,000 shares⁷$32.8K at $1.64Jul 8, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 20, 2026Gift 50,000 shares of Replimune Group, Inc.⁶
• May 18, 2026Sold 17,657 shares at $5.08 of Replimune Group, Inc.⁸
• Apr 1, 2026Granted 50,000 shares of Replimune Group, Inc.⁹
• Feb 18, 2026Gift 25,000 shares of Replimune Group, Inc.¹⁰
• May 20, 2025Sold 32,279 shares at $8.06 of Replimune Group, Inc.¹¹
• Aug 30, 2024Gift 50,000 shares of Replimune Group, Inc.¹²
• May 16, 2024Sold 37,928 shares at $6.47 of Replimune Group, Inc.¹³
• May 16, 2023Sold 17,902 shares at $18.05 of Replimune Group, Inc.¹⁴
• Apr 1, 2023Granted 142,100 shares of Replimune Group, Inc.¹⁵
• May 16, 2022Sold 9,632 shares at $14.59 of Replimune Group, Inc.¹⁶
• Apr 1, 2022Granted 70,000 shares of Replimune Group, Inc.¹⁷